{"id":"https://openalex.org/W4416670635","doi":"https://doi.org/10.1158/1078-0432.30709222","title":"Supplementary Methods S1 from B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy","display_name":"Supplementary Methods S1 from B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy","publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416670635","doi":"https://doi.org/10.1158/1078-0432.30709222"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30709222","doi":"https://doi.org/10.1158/1078-0432.30709222","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709222","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_S1_from_B-cell_Receptor_Pathway_Mutations_Are_Infrequent_in_Patients_with_Chronic_Lymphocytic_Leukemia_on_Continuous_Ibrutinib_Therapy/30709222/1/files/59834038.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_S1_from_B-cell_Receptor_Pathway_Mutations_Are_Infrequent_in_Patients_with_Chronic_Lymphocytic_Leukemia_on_Continuous_Ibrutinib_Therapy/30709222/1/files/59834038.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014241029","display_name":"Jennifer Ann Woyach","orcid":"https://orcid.org/0000-0002-3403-9144","observed_orcids":["https://orcid.org/0000-0002-3403-9144"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer A. Woyach","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3403-9144","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087770514","display_name":"Paolo Ghia","orcid":"https://orcid.org/0000-0003-3750-7342","observed_orcids":["https://orcid.org/0000-0003-3750-7342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paolo Ghia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3750-7342","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069774776","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0002-8778-1000","observed_orcids":["https://orcid.org/0000-0002-8778-1000"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8778-1000","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055037645","display_name":"Inhye E. Ahn","orcid":"https://orcid.org/0000-0003-3717-287X","observed_orcids":["https://orcid.org/0000-0003-3717-287X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inhye E. Ahn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3717-287X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056554686","display_name":"Carol Moreno","orcid":"https://orcid.org/0000-0003-3275-0271","observed_orcids":["https://orcid.org/0000-0003-3275-0271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol Moreno","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3275-0271","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006104041","display_name":"Susan Mary O'Brien","orcid":"https://orcid.org/0000-0002-2481-7504","observed_orcids":["https://orcid.org/0000-0002-2481-7504"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan M. O'Brien","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2481-7504","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070451207","display_name":"Dan M. Jones","orcid":"https://orcid.org/0000-0002-4688-3780","observed_orcids":["https://orcid.org/0000-0002-4688-3780"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Jones","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4688-3780","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076291201","display_name":"Leo W.K. Cheung","orcid":"https://orcid.org/0009-0004-8906-8366","observed_orcids":["https://orcid.org/0009-0004-8906-8366"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leo W.K. Cheung","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-8906-8366","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028857183","display_name":"Elizabeth Y. Chong","orcid":"https://orcid.org/0009-0003-8040-1348","observed_orcids":["https://orcid.org/0009-0003-8040-1348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Chong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-8040-1348","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030654523","display_name":"Kevin A. Kwei","orcid":"https://orcid.org/0009-0001-7936-7256","observed_orcids":["https://orcid.org/0009-0001-7936-7256"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Kwei","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-7936-7256","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103270876","display_name":"James P. Dean","orcid":"https://orcid.org/0000-0001-8058-1682","observed_orcids":["https://orcid.org/0000-0001-8058-1682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James P. Dean","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8058-1682","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081161234","display_name":"Danelle Frances James","orcid":"https://orcid.org/0000-0002-4434-8960","observed_orcids":["https://orcid.org/0000-0002-4434-8960"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danelle F. James","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4434-8960","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030524385","display_name":"Adrian U. Wiestner","orcid":"https://orcid.org/0000-0002-3533-2924","observed_orcids":["https://orcid.org/0000-0002-3533-2924"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrian Wiestner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3533-2924","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9850000143051147},{"id":"https://openalex.org/keywords/mutation-testing","display_name":"mutation testing","score":0.8360000252723694},{"id":"https://openalex.org/keywords/continuous-treatment","display_name":"continuous treatment","score":0.4090000092983246},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.48899999260902405}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.8906000256538391},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7419000267982483},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7139999866485596},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.5673999786376953},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5245000123977661},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.49000000953674316},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.37139999866485596},{"id":"https://openalex.org/C163565370","wikidata":"https://www.wikidata.org/wiki/Q4308623","display_name":"Mutation testing","level":4,"score":0.3249000012874603},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3093000054359436},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.3010999858379364},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28850001096725464},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.2768000066280365}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30709222","doi":"https://doi.org/10.1158/1078-0432.30709222","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709222","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_S1_from_B-cell_Receptor_Pathway_Mutations_Are_Infrequent_in_Patients_with_Chronic_Lymphocytic_Leukemia_on_Continuous_Ibrutinib_Therapy/30709222/1/files/59834038.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30709222","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_S1_from_B-cell_Receptor_Pathway_Mutations_Are_Infrequent_in_Patients_with_Chronic_Lymphocytic_Leukemia_on_Continuous_Ibrutinib_Therapy/30709222","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30709222","doi":"https://doi.org/10.1158/1078-0432.30709222","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30709222","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_S1_from_B-cell_Receptor_Pathway_Mutations_Are_Infrequent_in_Patients_with_Chronic_Lymphocytic_Leukemia_on_Continuous_Ibrutinib_Therapy/30709222/1/files/59834038.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416670635.pdf","grobid_xml":"https://content.openalex.org/works/W4416670635.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4380577673","https://openalex.org/W4402798854","https://openalex.org/W3096173394","https://openalex.org/W4214555549","https://openalex.org/W4385067443","https://openalex.org/W4377088465","https://openalex.org/W3133876073","https://openalex.org/W6989703399","https://openalex.org/W4378903117","https://openalex.org/W3102721453"],"abstract_inverted_index":{"Supplemental":[0],"methods":[1],"discussing":[2],"mutation":[3],"testing.":[4]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}